Literature DB >> 22395351

Prevalence of alloimmunisation in patients with beta thalassaemia major.

Mehrnoush Kosaryan, Mohammad Reza Mahdavi, Payam Roshan, Mohammad Taher Hojjati.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22395351      PMCID： PMC3417743          DOI： 10.2450/2012.0072-11

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  4 in total

Review 1.  Thalassemia intermedia: revisited.

Authors:  Ali Taher; Hussain Isma'eel; Maria D Cappellini
Journal:  Blood Cells Mol Dis       Date:  2006-06-05       Impact factor: 3.039

2.  Red cell immunization in beta thalassaemia major.

Authors:  Farhat Abbas Bhatti; Nuzhat Salamat; Ali Nadeem; Naveeda Shabbir
Journal:  J Coll Physicians Surg Pak       Date:  2004-11       Impact factor: 0.711

3.  Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases.

Authors:  H Schonewille; H L Haak; A M van Zijl
Journal:  Transfusion       Date:  1999-07       Impact factor: 3.157

Review 4.  Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.

Authors:  Banu Aygun; Savitri Padmanabhan; Carole Paley; Visalam Chandrasekaran
Journal:  Transfusion       Date:  2002-01       Impact factor: 3.157
  4 in total
  6 in total

Review 1.  Non-transfusion-dependent thalassemias.

Authors:  Khaled M Musallam; Stefano Rivella; Elliott Vichinsky; Eliezer A Rachmilewitz
Journal:  Haematologica       Date:  2013-06       Impact factor: 9.941

2.  Prevalence and specificities of red cell alloantibodies in transfusion-dependent beta thalassemia patients in Yazd.

Authors:  M Vaziri; H JavadzadehShahshahani; M Moghaddam; N Taghvaee
Journal:  Iran J Ped Hematol Oncol       Date:  2015-04-20

3.  Evaluation of Alloimmunization Rate and Necessity of Blood Type and Screening Test among Patients Candidate for Elective Surgery.

Authors:  Ahmad Gharehbaghian; Behrooz Ghezelbash; Sima Aghazade; Mohammad Taher Hojjati
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2014

Review 4.  When to consider transfusion therapy for patients with non-transfusion-dependent thalassaemia.

Authors:  A T Taher; A Radwan; V Viprakasit
Journal:  Vox Sang       Date:  2014-10-07       Impact factor: 2.144

Review 5.  Pregnancy in women with thalassemia: challenges and solutions.

Authors:  George Petrakos; Panagiotis Andriopoulos; Maria Tsironi
Journal:  Int J Womens Health       Date:  2016-09-08

6.  Rh-Matched Transfusion through Molecular Typing for β-Thalassemia Patients Is Required and Feasible in Chinese.

Authors:  Chao-Peng Shao; Cheng-Jiang Zhao; Chang-Lin Wu; Hua Xu; Xue-Dong Wang; Xiao-Ying Wu; Ping Yi; Xin-Tang Dang
Journal:  Transfus Med Hemother       Date:  2018-07-05       Impact factor: 3.747
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.